Clinical trial
SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
NCT04417114 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- April 1, 2021
- Completion date
- March 31, 2025
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular risk factor, psoriasis, psoriatic arthritis